OA
ACOR

OFI Advisors’s Acorda Therapeutics ACOR Stock Holding History

OFI Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$191K Hold
60
– – 0.01% 1222
2015
Q2 		$241K Buy
60
+6
+11% +$23.2K 0.01% 1156
2015
Q1 		$214K Buy
54
+16
+42% +$73.3K 0.01% 1206
2014
Q4 		$188K Sell
38
-8
-17% -$34.3K 0.01% 1241
2014
Q3 		$186K Buy
46
+7
+18% +$26.3K 0.01% 1191
2014
Q2 		$158K Buy
39
+8
+26% +$32.6K 0.01% 1283
2014
Q1 		$143K Sell
31
-6
-16% -$24.3K 0.01% 1283
2013
Q4 		$129K Buy
37
+12
+48% +$46.8K 0.01% 1307
2013
Q3 		$102K Buy
25
+4
+19% +$17.2K 0.01% 1325
2013
Q2 		$85K Buy
+21
New +$86.5K 0.01% 1341

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OFI Advisors's ACOR Position: Q3 2015 in Review

OFI Advisors held its Acorda Therapeutics (ACOR) position steady in Q3 2015 at 60 shares worth $191K. The position accounts for 0.01% of the portfolio, ranked #1222.

OFI Advisors first reported a position in ACOR in Q2 2013 and has held it in 10 quarters since. The position peaked at $241K in Q2 2015. 176 funds tracked by Wall St. Rank hold ACOR as of Q3 2015.

  • OFI Advisors held 60 shares of Acorda Therapeutics worth $191K as of Q3 2015.
  • OFI Advisors left its Acorda Therapeutics share count unchanged in Q3 2015.
  • Acorda Therapeutics made up 0.01% of OFI Advisors's portfolio in Q3 2015, its #1222 holding.
  • OFI Advisors first reported a position in Acorda Therapeutics in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Acorda Therapeutics position peaked at $241K in Q2 2015.
  • 176 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.